Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
Michael Gold1, Stefan Lorenzl2, Alistair J Stewart1, Bruce H Morimoto1, David R Williams3, Illana Gozes1,41Allon Therapeutics Inc, Vancouver, BC, Canada; 2Interdisciplinary Center for Palliative Medicine, Munich University Hospital Klinikum Grosshadern, Munich, Germany; 3Van Cleef/Roet Centre for Ne...
Guardado en:
Autores principales: | Gozes I, Williams DR, Morimoto BH, Stewart AJ, Lorenzl S, Gold M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec9d991512034ae7beea5a6b53c6d6e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
por: Piotr Alster, et al.
Publicado: (2021) -
La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder
por: van Meerkerk-Aanen PJ, et al.
Publicado: (2017) -
A case of atypical progressive supranuclear palsy
por: Spaccavento S, et al.
Publicado: (2013) -
Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia S, et al.
Publicado: (2012) -
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke C, et al.
Publicado: (2011)